February 13, 2025/
Bladder Cancer Treatment Advances: Combining ANKTIVA with BCG Bladder cancer continues to challenge both patients and clinicians, with over 500,000...
- Pi Health Cancer Hospital is committed to advancing cancer research and treatment innovation for a cancer-free future.
- We provide comprehensive holistic care, supported by ongoing research, optimizing personalized therapies through Early Detection and Screening initiatives that utilize advanced imaging and biomarkers for accessible cancer diagnosis.
- Our hospital’s integrated Clinical Research Centres conduct ground-breaking trials, evaluating novel cancer treatments while prioritizing participant safety.
- We offer advanced Genomic and Molecular Research for personalized cancer treatments, including targeted therapies and immunotherapy breakthroughs like immune checkpoint inhibitors, bringing hope to late-stage patients.
Research at Pi Health
Institutional Review Board
Research Faculty - Research Team
Clinical Trials
Proprietary Technology
Clinical Trials
FICS
1) A paradigm-Shifting healthcare Solution: FICS is positioned to become the world-leading platform for enabling efficient and cost-effective clinical trials
2) Connecting clinical care and research: As the first end-to-end software connecting clinical care and clinical research, FICS will deliver breakthrough solutions for sites and sponsors
Our clinical trials at Pi Health cancer hospital are groundbreaking research studies focused on advancing cancer treatment. These trials involve carefully monitored treatments and therapies to assess their effectiveness and safety. Our dedicated team of experts is committed to pushing the boundaries of cancer care and finding new ways to fight these diseases.
About trials:
Phases of Clinical Trials: Clinical trials are typically conducted in several phases:
• Phase 1: Small group of healthy volunteers to test safety and dosage.
• Phase 2: Larger group to assess effectiveness and further safety.
• Phase 3: Even larger group to confirm effectiveness, monitor side effects, and compare to
standard treatments.
• Phase 4: Post-market surveillance after the treatment is approved to monitor long-term safety and
effectiveness.
Find clinical trials:
Ongoing trials: Phase II study on tislelizumab for NSCLC/ Head & Neck cancer patients
Media
- News
- Blog
February 12, 2025/
The Role of Bacillus Calmette-Guerin (BCG) in Bladder Cancer Treatment Bladder cancer is one of the most common types of...
February 5, 2025/
What You Should Know About Chronic Myelogenous Leukemia (CML) Chronic Myelogenous Leukemia (CML) is a type of blood cancer that...
Volunteering for Trial Participation
Volunteers play a crucial role in the research process, contributing significantly to medical advancements. Both individuals affected by a specific disease and those in good health can actively participate in clinical studies. The absence of volunteers would render clinical research unfeasible.
There are various motivations driving people to volunteer for clinical studies. These include:
- A commitment to enhancing medical care for future generations.
- Personal connections to a specific disease or ailment, whether through personal experiences or through connections with friends or family.
- A genuine passion for scientific exploration.